Commercial Sterile Fill-Finish Locations
Bulk Capacity
1-1200 L
GMP Dose Filling Lines
Vials, syringes & cartridges
Validated For
2 – 100 mL vials 1 – 10 mL syringes
Non-cyto
Liquid and lyophilized
Cyto/Highly Potent
Liquid and lyophilized
Expertise and Capabilities
- Microfluidization/high-shear homogenization/extrusion
- Suspensions/emulsions/liposomal/nanoparticles
- Small molecule
- Proteins/peptides/oligonucleotides
- Monoclonal antibodies (mAbs)
- Inactivated and attenuated live virus
- Late phase clinical and commercial
- Full in-house QC /Microbiology services (including sterility testing)
- Stability Services
Quality and Regulatory
- FDA and EU Approved
- DEA registration for Schedule II-V controlled substances
Bulk Capacity
1 – 200 L
GMP Dose Filling Lines
Vials and syringes
Validated For
2 – 50 mL vials 1 – 10 mL syringes
Non-cyto
Liquid and lyophilized
Cyto/Highly Potent
Liquid
Expertise and Capabilities
- Process Development
- Highly viscous formulations
- Microfluidization/high-shear homogenization/extrusion
- Suspensions/emulsions/liposomal/nanoparticles
- Small molecule
- Proteins/peptides/oligonucleotides
- Monoclonal antibodies (mAbs)
- Clinical and commercial
- In-house QC capabilities
- Stability Services
Quality and Regulatory
- FDA and EU Approved
- DEA registration for Schedule II-V controlled substances
The power of a partnership with Curia
Extensive catalog
Access to a robust portfolio of more than 240 generic and commercial APIs
Global network
12+ GMP facilities in the US, France, Italy, Spain, UK and India
Regulator inspected
Facilities successfully inspected by the FDA, PMDA, KFDA, ANVISA, MHRA and AIFA
SafeBridge® certified
Industry leadership in safe handling of potent APIs
Controlled substance capable
DEA registrations for manufacturing, research and export of Schedule I-V
Ready to realize your product’s full potential on your schedule?
